CLOs on the Move

Bear Mountain Forest Products

www.bmfp.com

 
Bear Mountain Forest Products is a Cascade Locks, OR-based company in the Manufacturing sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.bmfp.com

  • Cascade Locks, OR USA 97014
  • Phone: 541.374.8844

Executives

Name Title Contact Details

Similar Companies

Voodoo lab

Voodoo Lab has designed and manufactured professional electronics for recording and touring musicians since 1986. Rugged, reliable and handmade from the finest components, every product is hand built one at a time in our Northern California facility. Created and built by musicians for musicians, all Voodoo Lab products deliver pure, richly detailed tones that can be heard on the biggest stages worldwide. Whether you`re a stompbox junkie, or putting together the ultimate programmable rig that incorporates rack gear and vintage pedals, Voodoo Lab can help you achieve the sounds you`re looking for.

Dynamic Blending Specialists

Dynamic Blending is a contract manufacturer for private label cosmetics. We help you produce skincare, lip care, oral care, hair care, body care, and more!

Robbins Manufacturing Co

Robbins Manufacturing Co is a Tampa, FL-based company in the Manufacturing sector.

ASC Seafood

ASC Seafood is a Largo, FL-based company in the Manufacturing sector.

CytoSorbents

CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood purification. Its flagship product, CytoSorb®, is approved in the European Union, distributed in 75 countries worldwide, and has accumulated more than 212,000 human treatments to date, to reduce "cytokine storm" and other toxins that can cause organ failure. The DrugSorb™-ATR antithrombotic removal system, based on the same polymer technology as CytoSorb, has received two U.S. FDA Breakthrough Device Designations to remove two separate blood thinners during cardiothoracic surgery, including ticagrelor and the direct oral anticoagulants (DOAC) apixaban and rivaroxaban, and is undergoing pivotal clinical studies.